Prezzo AstraZeneca xStock
AZNXRank 4917
AstraZeneca xStock (AZNX) Grafico dei prezzi in tempo reale
AstraZeneca xStock (AZNX) prezzo oggi è $93.7, con un volume di scambi in 24 ore di $69.22 e come tale AstraZeneca xStock (AZNX) ha una capitalizzazione di mercato di $94.82K, dandogli una dominance di mercato di 0.0015%. Il prezzo di AstraZeneca xStock (AZNX) ha registrato un -0.29% nelle ultime 24 ore.
AZNX Dati sui prezzi
- 24h Turnover$69.22
- Massimo storico(ATH)$327.27
- Massimo 24h$94.24
- Il minimo storico(ATL)$71.27
- Minimo 24h$93.65
AZNX Informazioni sulla capitalizzazione di mercato
- Cap. di mercato$94.82K
- Valutazione completamente diluita$43.54M
- Cap. di mercato/FDV0.22%
- Sentimento del mercatoNeutrale
AZNX Offerta
- Fornitura in circolazione1.01K AZNX
- Fornitura totale464.76K AZNX
- Fornitura massima∞
*I dati sono solo di riferimento
Si prevede che AstraZeneca xStock (AZNX) avrà una media di $93.7 in 2026, con una potenziale oscillazione tra il prezzo più basso $48.72 e il prezzo più alto $132.11. Entro 2031, il prezzo di AstraZeneca xStock(AZNX) potrebbe raggiungere il $201.52, offrendo un potenziale rendimento +106.00% rispetto al prezzo AstraZeneca xStock odierno.
Anno | Prezzo minimo | Prezzo più alto | Average price | Modifica |
|---|---|---|---|---|
2026 | $48.72 | $132.11 | $93.7 | -- |
2027 | $85.81 | $133.23 | $112.9 | +20.00% |
2028 | $83.68 | $180.91 | $123.07 | +31.00% |
2029 | $85.11 | $205.18 | $151.99 | +62.00% |
2030 | $137.51 | $208.95 | $178.59 | +90.00% |
2031 | $125.95 | $201.52 | $193.77 | +106.00% |
AstraZeneca xStock(AZNX) il prezzo è aumentato di -0.29% nelle ultime 24 ore e di -2.37% negli ultimi 7 giorni. Il prezzo di AstraZeneca xStock(AZNX) è -8.66% negli ultimi 30 giorni, e +39.37% nell'ultimo anno.
Periodo di tempo | Importo residuo | Variazione % |
|---|---|---|
1H | +$0.04682 | +0.05% |
24H | -$0.2725 | -0.29% |
7D | -$2.27 | -2.37% |
30D | -$8.88 | -8.66% |
1Y | +$26.46 | +39.37% |
A proposito di AstraZeneca xStock (AZNX)
Contratto
xs3zfkpyt...sq1z3waku
Explorer
explorer.solana.com
Sito Web
xstocks.com
Notizie
Tag
AstraZeneca xStock (AZNx) is a tracker certificate issued as Solana SPL and ERC-20 tokens. AZNx tracks the price of AstraZeneca company stock (the underlying). AZNx is designed to give eligible cryptocurrency market participants regulatory-compliant access to the price of AstraZeneca company stock
- GateNewsAccording to sources, OPEC+ agreed in principle on May 2 to increase June crude oil production by 188,000 barrels per day, with the formal decision expected to be announced on May 3 following an OPEC+ member state meeting. This marks the first policy decision since the United Arab Emirates
- GateNewsAccording to Bloomberg, Roblox is launching new AI software to compete with Unity Technologies and Epic Games, whose engines dominate large-budget game development. CEO Dave Baszucki stated the tool aims to help creators build multiplayer games with photorealistic graphics more easily, powered by ar
- GateNewsAccording to Bloomberg, AI chip manufacturer Cerebras Systems is seeking to raise up to $4 billion in its initial public offering with a target valuation of approximately $40 billion. The California-based company plans to launch its IPO roadshow as early as Monday (May 5). Underwriters have
- GateNewsAccording to Tanker Trackers, on May 3, an Iranian supertanker operated by National Iranian Oil Company carrying over 1.9 million barrels of crude oil valued at approximately $220 million successfully evaded U.S. Navy tracking. The vessel is currently transiting the Lombok Strait and heading
- GateNewsAccording to Cointelegraph, Chris Perkins, CEO of 250 Digital Asset Management, stated that even if the Clarity Act fails to pass through Congress, the long-term development of the U.S. crypto industry will not be affected. Perkins noted that the SEC and CFTC are continuing to establish regulatory f
- GateNewsAccording to The Block, BlackRock submitted a 17-page comment letter to the Office of the Comptroller of the Currency on Friday (May 2), urging the agency to reject a proposed 20% quantitative cap on tokenized reserve assets in the GENIUS Act implementation rules. BlackRock argued that such limits a
